Page 3 - தலைகீழ் ஸ்டாக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தலைகீழ் ஸ்டாக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தலைகீழ் ஸ்டாக் Today - Breaking & Trending Today

AMERI Holdings Announces 1-for-4 Reverse Stock Split


Share this article
Share this article
ATLANTA, Dec. 30, 2020 /PRNewswire/  AMERI Holdings, Inc. (NASDAQ: AMRH) ( Ameri , the Company ), announced a 1-for-4 reverse split of its common stock, effective as of 4:02 pm Eastern Time, December 30, 2020 (the Reverse Stock Split ).
As previously announced, at the special meeting of stockholders held on December 29, 2020, Ameri s stockholders approved all proposals to complete the proposed tender offer (the Offer ), whereby Ameri will purchase all of the outstanding common shares of Jay Pharma Inc. ( Jay Pharma ) in exchange for shares of Ameri common stock, or if applicable, shares of Ameri preferred stock, at the exchange ratio set forth in the Tender Offer Support Agreement and Termination of Amalgamation Agreement dated August 12, 2020, among Ameri, Jay Pharma and certain other signatories thereto, as amended (the Tender Agreement ), wherein Jay Pharma will become a wholly-owned subsidiary of Ameri, on the terms and ....

United States , Barry Kostiner , Jay Pharma , Enveric Biosciences , Equiniti Trust Company , Holdings Inc , Ameri Holdings Investor Relations Contact , Jay Pharma Inc , Enveric Biosciences Inc , Eastern Time , Tender Offer Support Agreement , Amalgamation Agreement , Tender Agreement , Reverse Stock , Delaware Secretary , Reverse Stock Split , Seriesb Preferred Stock , Nasdaq Capital Market , Ameri Investor , Annual Report , Securities Act , Nasdaq Capital , Chief Financial , Holdings Investor Relations Contact , ஒன்றுபட்டது மாநிலங்களில் , ஜெய் பார்மா ,

KemPharm Announces 1-for-16 Reverse Stock Split


KemPharm Announces 1-for-16 Reverse Stock Split
December 23, 2020 18:11 ET
| Source:
KemPharm
KemPharm
Celebration, Florida, UNITED STATES
CELEBRATION, Fla., Dec. 23, 2020 (GLOBE NEWSWIRE) KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that the Company s Board of Directors has approved a 1-for-16 reverse stock split of its shares of common stock (“Reverse Stock Split”). KemPharm’s stockholders granted authority to the Board of Directors to effect this Reverse Stock Split of KemPharm’s common stock at the Special Meeting of Stockholders held on November 17, 2020. The Reverse Stock Split is intended to enable the Company to potentially regain its listing on the Nasdaq Capital Market. ....

Computershare Trust Company , Company Board Of Directors , Exchange Commission , Securities Exchange , Kempharm Inc , Reverse Stock Split , Special Meeting , Nasdaq Capital , Reverse Stock , Venture Market , Ligand Activated Therapy , Concerning Forward Looking Statements , Securities Act , Securities Exchange Act , Nasdaq Capital Market , Annual Report , Quarterly Report , Current Reports , Other Otc Kmph , கணினி பகிர்வு நம்பிக்கை நிறுவனம் , நிறுவனம் பலகை ஆஃப் இயக்குநர்கள் , பரிமாற்றம் தரகு , பத்திரங்கள் பரிமாற்றம் , தலைகீழ் ஸ்டாக் பிளவு , சிறப்பு சந்தித்தல் , நாஸ்டாக் மூலதனம் ,